Skip to main content
Transportation Update Actualización de transporte

SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.

Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.

Learn more

SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.

Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.

Obtenga más información AQUI

Class I Drug Recall Notification: Cyclobenzaprine 10 mg

Date: September 2, 2025

Attention: All Providers

Effective date: August 27, 2025

Call to action: Texas Children’s Health Plan (TCHP) would like inform providers that effective August 27, 2025, Unichem Pharmaceuticals (USA), Inc. voluntarily recalled one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg to the consumer level. The Cyclobenzaprine 10 mg (90-count) label was inadvertently placed on bottles containing Meloxicam 7.5 mg tablets.

Product affected:

Impacted MedicationNDC No.Lot No.Expiration Date
CYCLOBENZAPRINE HYDROCHLORIDE TABELTS USP 10 MG29300-415-19GMML24026ASept 2027

How this impacts providers: This recall may affect providers whose patients were dispensed the impacted lot, as members may unknowingly be taking Meloxicam instead of Cyclobenzaprine. This could result in ineffective therapy for muscle spasms as well as the potential for adverse effects associated with unintended NSAID use. Providers should be aware that affected patients may contact their offices with questions or concerns and may need counseling regarding discontinuation of the recalled product and appropriate replacement therapy.

Next step for providers: Providers should inform their impacted patients and arrange for the return and replacement of the drug.

If you have any questions, please email TCHP Pharmacy at: providerrelations@texaschildrens.org

For access to all provider alerts,log into:
www.texaschildrenshealthplan.org/provideralerts.